atc_code
stringlengths 1
7
| atc_name
stringlengths 3
95
| ddd
float64 0.1
800
⌀ | uom
stringclasses 10
values | adm_r
stringclasses 18
values | note
stringclasses 96
values |
|---|---|---|---|---|---|
C10BX01 | simvastatin and acetylsalicylic acid | 30 | mg | O | Refers to simvastatin |
R05FB02 | cough suppressants and expectorants | null | null | null | null |
N03AF01 | carbamazepine | 1 | g | O | null |
N02BG04 | floctafenine | 1 | g | O | null |
C07AG01 | labetalol | 0.6 | g | P | null |
A07FA51 | lactic acid producing organisms, combinations | null | null | null | null |
V01AA03 | house dust mites | null | null | null | null |
D06AA03 | oxytetracycline | null | null | null | null |
V09AX | Other central nervous system diagnostic radiopharmaceuticals | null | null | null | null |
J01XX12 | lefamulin | null | null | null | null |
J01EB03 | sulfadimidine | 4 | g | O | null |
H | SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS | null | null | null | null |
A11HA01 | nicotinamide | 0.15 | g | O | null |
J02AX01 | flucytosine | 10 | g | P | null |
B03AA08 | ferrous tartrate | 0.2 | g | O | Fe2+ |
N05AD06 | bromperidol | 10 | mg | P | null |
C01CE04 | bucladesine | null | null | null | null |
L01BC52 | fluorouracil, combinations | null | null | null | null |
C03AA | Thiazides, plain | null | null | null | null |
L01EG | Mammalian target of rapamycin (mTOR) kinase inhibitors | null | null | null | null |
C03AX | Thiazides, combinations with other drugs | null | null | null | null |
L04 | IMMUNOSUPPRESSANTS | null | null | null | null |
M09AX02 | chondrocytes, autologous | null | null | null | null |
R05CB07 | sobrerol | null | null | null | null |
V09IA09 | technetium (99mTc) tilmanocept | null | null | null | null |
N05CH | Melatonin receptor agonists | null | null | null | null |
S01EB05 | physostigmine | 0.4 | ml | null | null |
M01AB13 | oxametacin | null | null | null | null |
H05BA04 | elcatonin | null | null | null | null |
P02CA06 | fenbendazole | null | null | null | null |
N05BA23 | tofisopam | null | null | null | null |
C01DA | Organic nitrates | null | null | null | null |
A02BC07 | dexrabeprazole | null | null | null | null |
C07AG | Alpha and beta blocking agents | null | null | null | null |
C01DX22 | vericiguat | null | null | null | null |
S01AB05 | sulfafenazol | null | null | null | null |
M02AA06 | etofenamate | null | null | null | null |
H03B | ANTITHYROID PREPARATIONS | null | null | null | null |
R03DX02 | eprozinol | null | null | null | null |
J05AR12 | lamivudine and tenofovir disoproxil | null | null | null | null |
M01AE17 | dexketoprofen | 75 | mg | P | null |
G03AA10 | gestodene and ethinylestradiol | null | null | null | null |
B01AD02 | alteplase | 0.1 | g | P | null |
C10AB09 | etofibrate | null | null | null | null |
A05BA05 | epomediol | null | null | null | null |
R06AD | Phenothiazine derivatives | null | null | null | null |
S01HA07 | lidocaine | null | null | null | null |
N04AB02 | orphenadrine (chloride) | 0.2 | g | P | null |
P01CC | Nitrofuran derivatives | null | null | null | null |
C05 | VASOPROTECTIVES | null | null | null | null |
B01AD08 | saruplase | null | null | null | null |
R05CA13 | cineole | null | null | null | null |
C03EA01 | hydrochlorothiazide and potassium-sparing agents | null | null | null | null |
N01BB57 | etidocaine, combinations | null | null | null | null |
D07AA03 | prednisolone | null | null | null | null |
D11AX52 | gamolenic acid, combinations | null | null | null | null |
A11HA03 | tocopherol (vit E) | 0.2 | g | O | null |
A12BA51 | potassium chloride, combinations | null | null | null | null |
V08AC01 | iodoxamic acid | null | null | null | null |
N05AA05 | triflupromazine | 0.1 | g | P | null |
A04AD04 | chlorobutanol | null | null | null | null |
L01EJ | Janus-associated kinase (JAK) inhibitors | null | null | null | null |
N03AX17 | stiripentol | 1 | g | O | null |
V04CG04 | pentagastrin | null | null | null | null |
N06DX01 | memantine | 20 | mg | O | null |
D11AH06 | crisaborole | null | null | null | null |
S01CA11 | clobetasone and antiinfectives | null | null | null | null |
C07DB | Beta blocking agents, selective, thiazides and other diuretics | null | null | null | null |
J01DC07 | cefotiam | 4 | g | P | null |
N01AG | Barbiturates in combination with other drugs | null | null | null | null |
R05FB01 | cough suppressants and mucolytics | null | null | null | null |
D01AC05 | isoconazole | null | null | null | null |
N05CA04 | barbital | 0.5 | g | O | null |
A02AD04 | hydrotalcite | null | null | null | null |
J01XD03 | ornidazole | 1 | g | P | null |
J01CG02 | tazobactam | null | null | null | null |
C01CA01 | etilefrine | 50 | mg | O | null |
C05AD04 | cinchocaine | null | null | null | null |
N04 | ANTI-PARKINSON DRUGS | null | null | null | null |
H05BX03 | doxercalciferol | null | null | null | null |
M01AX02 | niflumic acid | 0.75 | g | O | null |
D08AA01 | ethacridine lactate | null | null | null | null |
V03AN03 | helium | null | null | null | null |
C05BX | Other sclerosing agents | null | null | null | null |
B05BA | Solutions for parenteral nutrition | null | null | null | null |
L01AA07 | trofosfamide | null | null | null | null |
S02AA | Antiinfectives | null | null | null | null |
N03AB54 | mephenytoin, combinations | null | null | null | null |
C04AF01 | kallidinogenase | 30 | U | O | null |
N04BA05 | melevodopa and decarboxylase inhibitor | null | null | null | null |
C09BA03 | lisinopril and diuretics | null | null | null | null |
V08AA08 | iocarmic acid | null | null | null | null |
C04AC02 | nicotinyl alcohol (pyridylcarbinol) | 0.3 | g | P | null |
B02BA02 | menadione | 2 | mg | P | null |
H03BB01 | carbimazole | 15 | mg | O | null |
N03AX18 | lacosamide | 0.3 | g | O | null |
G01AA | Antibiotics | null | null | null | null |
A16AB18 | vestronidase alfa | null | null | null | null |
G04BD | Drugs for urinary frequency and incontinence | null | null | null | null |
H02B | CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS | null | null | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.